FI891700L - Menetelmä beta-laktaamijohdannaisten valmistamiseksi - Google Patents

Menetelmä beta-laktaamijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI891700L
FI891700L FI891700A FI891700A FI891700L FI 891700 L FI891700 L FI 891700L FI 891700 A FI891700 A FI 891700A FI 891700 A FI891700 A FI 891700A FI 891700 L FI891700 L FI 891700L
Authority
FI
Finland
Prior art keywords
lactam derivatives
preparing beta
beta
preparing
lactam
Prior art date
Application number
FI891700A
Other languages
English (en)
Swedish (sv)
Other versions
FI93731C (fi
FI891700A0 (fi
FI93731B (fi
Inventor
Pierluigi Bissolino
Marco Alpegiani
Ettore Perrone
Piergiuseppe Orezzi
Giuseppe Cassinelli
Giovanni Franceschi
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of FI891700A0 publication Critical patent/FI891700A0/fi
Publication of FI891700L publication Critical patent/FI891700L/fi
Application granted granted Critical
Publication of FI93731B publication Critical patent/FI93731B/fi
Publication of FI93731C publication Critical patent/FI93731C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
FI891700A 1988-04-13 1989-04-11 Menetelmä beta-laktaamijohdannaisten valmistamiseksi FI93731C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808701A GB8808701D0 (en) 1988-04-13 1988-04-13 Beta-lactam derivatives
GB8808701 1988-04-13

Publications (4)

Publication Number Publication Date
FI891700A0 FI891700A0 (fi) 1989-04-11
FI891700L true FI891700L (fi) 1989-10-14
FI93731B FI93731B (fi) 1995-02-15
FI93731C FI93731C (fi) 1995-05-26

Family

ID=10635113

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891700A FI93731C (fi) 1988-04-13 1989-04-11 Menetelmä beta-laktaamijohdannaisten valmistamiseksi

Country Status (23)

Country Link
US (1) US5077286A (fi)
EP (1) EP0337704B1 (fi)
JP (1) JP2840286B2 (fi)
KR (1) KR0138771B1 (fi)
CN (1) CN1037151A (fi)
AT (1) ATE123778T1 (fi)
AU (1) AU615048B2 (fi)
CA (1) CA1325077C (fi)
DE (1) DE68923033T2 (fi)
DK (1) DK175689A (fi)
ES (1) ES2075850T3 (fi)
FI (1) FI93731C (fi)
GB (1) GB8808701D0 (fi)
GR (1) GR3017081T3 (fi)
HU (1) HU206118B (fi)
IE (1) IE67549B1 (fi)
IL (1) IL89929A0 (fi)
MY (1) MY104428A (fi)
NO (1) NO173016C (fi)
NZ (1) NZ228681A (fi)
SU (2) SU1750430A3 (fi)
YU (1) YU47481B (fi)
ZA (1) ZA892629B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5132301A (en) * 1983-05-02 1992-07-21 Merck & Co., Inc. Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
GB8811388D0 (en) * 1988-05-13 1988-06-15 Erba Carlo Spa 1,1-dioxo-cephem-4-carbothiolic acid derivatives
AU661453B2 (en) * 1989-10-06 1995-07-27 Synphar Laboratories, Inc. Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof
US5264429A (en) * 1989-10-06 1993-11-23 Synphar Laboratories, Inc. 2-spirocyclopropyl cephalosporin sulfone derivatives
GB8928373D0 (en) * 1989-12-15 1990-02-21 Erba Carlo Spa Beta-lactam derivatives
GB9011463D0 (en) * 1990-05-22 1990-07-11 Erba Carlo Spa Process for the preparation of 7 alpha-alkoxycephem derivatives
ATE164074T1 (de) * 1990-05-24 1998-04-15 Zeneca Ltd Therapeutisches mittel zur vorbeugung und behandlung des atemnotsyndroms bei erwachsenen
DK0458537T3 (da) * 1990-05-24 1999-10-18 Zeneca Ltd Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis
US5258377A (en) * 1991-04-08 1993-11-02 Taiho Pharmaceutical Co., Ltd. 2-spirocyclopropyl 4-acylcephems
US5446037A (en) * 1991-12-05 1995-08-29 Synphar Laboratories, Inc. 2-[(substituted) methylene]cephalosporin sulfones as antiinflammatory, antidegenerative and antithrombin agents
WO1993016043A1 (en) * 1992-02-18 1993-08-19 Otsuka Kagaku Kabushiki Kaisha β-LACTAM COMPOUND AND CEPHEM COMPOUND, AND PRODUCTION THEREOF
GB9207715D0 (en) * 1992-04-08 1992-05-27 Erba Carlo Spa 2,2-disubstituted cephem sulphones
WO1993024493A1 (en) * 1992-05-27 1993-12-09 Teijin Limited Cephalosporin derivative
GB2273097B (en) * 1992-12-04 1996-09-18 Erba Carlo Spa 4-Alkyl and 4-alkenyl delta-3-cephem sulphone human leukocyte elastase inhibitors
EP0682526B1 (en) 1993-02-12 2002-09-04 Avant Immunotherapeutics, Inc. PULMONARY ADMINISTRATION OF THE SOLUBLE COMPLEM RECEPTOR TYPE 1 sCR1
GB9304440D0 (en) * 1993-03-04 1993-04-21 Erba Carlo Spa 2-acyloxycephem derivatives
US5439904A (en) * 1993-12-07 1995-08-08 Synphar Laboratories, Inc. 2-spiro(2'-spirocycloalkyl)cyclopropyl cephalosporin sulfones as antiinflammatory and antigenerative agents
US5597817A (en) * 1994-12-09 1997-01-28 Southern Methodist University 7-vinylidene cephalosporins and methods of using the same
US5629306A (en) 1994-12-09 1997-05-13 Research Corporation Technologies, Inc. 7-alkylidene cephalosporanic acid derivatives and methods of using the same
GB9513818D0 (en) * 1995-07-06 1995-09-06 Pharmacia Spa 7,7-Disubstituted cephem-4-ketones
US5760027A (en) * 1996-12-06 1998-06-02 Research Corporation Technologies, Inc. Use of 7-alkylidene cephalosporins to inhibit elastase activity
US6407091B1 (en) * 1999-04-15 2002-06-18 Research Corporation Technologies, Inc. β-lactamase inhibiting compounds
BRPI0413908A (pt) * 2003-08-25 2006-10-24 Revaax Pharmaceuticals Llc formulação farmacêutica neuroterapêutica em forma de dosagem oral, composto, e, método de tratamento de um distúrbio comportamental ou um distúrbio cognitivo

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3799922A (en) * 1971-11-17 1974-03-26 Smithkline Corp 4-substituted 3-cephem compounds
IN149747B (fi) * 1977-06-07 1982-04-03 Pfizer
NZ190797A (en) * 1978-06-06 1982-08-17 Pfizer Combination of penicillanic 1,1-dioxide and 7-(d-2-(4-ethylpiperazin-2 3-dione-1-carboxamido)-2-(4-hydroxphenyl)acetamido)-3-(1-methyl-5-tetrazolyl)-thiomethyl-3-desacetoxymethylcephalosporanic acid
NZ193020A (en) * 1979-03-05 1982-11-23 Pfizer Preparation of penicillanic acid 1,1-dioxide and intermediates therefor
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4381263A (en) * 1981-03-23 1983-04-26 Pfizer Inc. Process for the preparation of penicillanic acid esters
IN159362B (fi) * 1981-03-23 1987-05-09 Pfizer
US4547371A (en) * 1983-04-18 1985-10-15 Merck & Co., Inc. Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
US4637999A (en) * 1983-05-02 1987-01-20 Merck & Co., Inc. Substituted cephalosporins as anti-inflammatory and antidegenerative agents
EP0124081A3 (en) * 1983-05-02 1986-11-26 Merck & Co. Inc. New substituted cephalosporin sulfones as antiinflammatory and antidegenerative agents, pharmaceutical compositions containing the same and processes for making them
US4468351A (en) * 1983-06-06 1984-08-28 Pfizer Inc. Process for debromination of dibromopenicillanic acid and derivatives
JPS62284386A (ja) * 1986-06-03 1987-12-10 日立電子エンジニアリング株式会社 プロ−ビング方式
ATE133954T1 (de) * 1986-11-12 1996-02-15 Merck & Co Inc Substituierte cephalosporinsulfone als anti- entzündliche und anti-degenerative mittel

Also Published As

Publication number Publication date
GB8808701D0 (en) 1988-05-18
NO891516L (no) 1989-10-16
FI93731C (fi) 1995-05-26
KR0138771B1 (ko) 1998-05-15
JPH0228183A (ja) 1990-01-30
YU74489A (en) 1991-02-28
MY104428A (en) 1994-03-31
ATE123778T1 (de) 1995-06-15
JP2840286B2 (ja) 1998-12-24
ES2075850T3 (es) 1995-10-16
HUT50348A (en) 1990-01-29
DE68923033D1 (de) 1995-07-20
US5077286A (en) 1991-12-31
AU615048B2 (en) 1991-09-19
NO173016B (no) 1993-07-05
SU1750430A3 (ru) 1992-07-23
IE67549B1 (en) 1996-04-17
HU206118B (en) 1992-08-28
ZA892629B (en) 1989-12-27
IL89929A0 (en) 1989-12-15
SU1766261A3 (ru) 1992-09-30
AU3276289A (en) 1989-10-19
NO173016C (no) 1993-10-13
CA1325077C (en) 1993-12-07
NZ228681A (en) 1991-07-26
IE891132L (en) 1989-10-13
KR890016048A (ko) 1989-11-28
NO891516D0 (no) 1989-04-12
DE68923033T2 (de) 1995-10-26
DK175689D0 (da) 1989-04-12
FI891700A0 (fi) 1989-04-11
YU47481B (sh) 1995-10-03
CN1037151A (zh) 1989-11-15
DK175689A (da) 1989-10-14
EP0337704A3 (en) 1991-09-25
EP0337704A2 (en) 1989-10-18
FI93731B (fi) 1995-02-15
GR3017081T3 (en) 1995-11-30
EP0337704B1 (en) 1995-06-14

Similar Documents

Publication Publication Date Title
FI891700L (fi) Menetelmä beta-laktaamijohdannaisten valmistamiseksi
KR860005811A (ko) 티아졸리딘디온 유도체의 제조방법
FI893158L (fi) Menetelmä tetrahydrofolaattien valmistamiseksi
FI890282L (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI893361L (fi) Menetelmä ACAT-inhiboivien kinoliinijohdannaisten valmistamiseksi
FI892850L (fi) Menetelmä uusien hepariinijohdannaisten valmistamiseksi
FI905941A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
PT88596A (pt) Process for preparing 2-anilinopyrimidine derivatives useful aspesticidas
BG49939A3 (bg) Метод за получаване на 2-анилино-пиримидинови производни
FI894217L (fi) 1-adamantaanijohdannaisten valmistusmenetelmä
FI893100L (fi) Analogiamenetelmä asyylideoksiribonukleosidijohdannaisten valmistamiseksi
FI892182A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI891711L (fi) Menetelmä diorganodialkoksisilaanien valmistamiseksi
FI881904A7 (fi) Menetelmä 3-kefeemijohdannaisten valmistamiseksi
FI943643A7 (fi) Menetelmä taksaanijohdannaisten valmistamiseksi
KR860004897A (ko) 세팔로스포린 유도체의 제조방법
FI863776A7 (fi) Menetelmä 7-aminomitosaanijohdannaisten valmistamiseksi.
FI892948A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI893003L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI923498A7 (fi) Menetelmä 3-deoksimannosamiini-johdannaisten valmistamiseksi
FI906203A7 (fi) Glyserolijohdosten valmistusmenetelmä
FI891362A7 (fi) Menetelmä uusien alkanofenonien valmistamiseksi
KR870001175A (ko) 5-치환된-6-아미노피리미딘 유도체의 제조방법
FI895800A7 (fi) Menetelmä uusien a-syano-b-oksopropioniamidien valmistamiseksi
FI892420A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminoetanolijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: PHARMACIA & UPJOHN S.P.A.

MM Patent lapsed
MM Patent lapsed

Owner name: PHARMACIA & UPJOHN S., P.A.